|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/416 | |||
| A61K 31/513 | |||
| A61K 31/517 | |||
| A61K 31/5355 | |||
| A61K 31/555 | |||
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| G01N 33/574 | |||
| A61K 47/48 | |||
| A61K 31/5377 |
| (11) | Number of the document | 2254571 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09721522.2 |
| Date of filing the European patent application | 2009-03-10 | |
| (97) | Date of publication of the European application | 2010-12-01 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/036608 |
| Date | 2009-03-10 |
| (87) | Number | WO 2009/117277 |
| Date | 2009-09-24 |
| (30) | Number | Date | Country code |
| 37410 P | 2008-03-18 | US |
| (72) |
BERRY, Leanne, US
PHILLIPS, Gail, Lewis, US
SLIWKOWSKI, Mark, X., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE |
| COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE |